Cargando…

Determinants of plasma calretinin in patients with malignant pleural mesothelioma

OBJECTIVE: Calretinin is a well-known immunohistochemical tissue marker in the diagnosis of malignant mesothelioma. Promising results also indicate the use in early detection. In the present cross-sectional survey, correlations of calretinin plasma levels with clinical features were investigated. Pl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehnert, Martin, Weber, Daniel G., Taeger, Dirk, Raiko, Irina, Kollmeier, Jens, Stephan-Falkenau, Susann, Brüning, Thomas, Johnen, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391805/ https://www.ncbi.nlm.nih.gov/pubmed/32727552 http://dx.doi.org/10.1186/s13104-020-05187-y

Ejemplares similares

Calretinin as a blood-based biomarker for mesothelioma
por: Johnen, Georg, et al.
Publicado: (2017)

Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients
por: Raiko, Irina, et al.
Publicado: (2010)

Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin – a case-control comparison nested into a prospective cohort of asbestos-exposed workers
por: Johnen, Georg, et al.
Publicado: (2018)

Assessment of potential predictors of calretinin and mesothelin to improve the diagnostic performance to detect malignant mesothelioma: results from a population-based cohort study
por: Casjens, Swaantje, et al.
Publicado: (2017)

Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of malignant mesothelioma using liquid biopsies
por: Weber, Daniel G., et al.
Publicado: (2020)

Mesothelin Gene Variants Affect Soluble Mesothelin-Related Protein Levels in the Plasma of Asbestos-Exposed Males and Mesothelioma Patients from Germany
por: Rihs, Hans-Peter, et al.
Publicado: (2022)

Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
por: Jiménez-Ramírez, Carmina, et al.
Publicado: (2022)

Are circulating microRNAs suitable for the early detection of malignant mesothelioma? Results from a nested case–control study
por: Weber, Daniel Gilbert, et al.
Publicado: (2019)

Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma
por: Weber, Daniel G., et al.
Publicado: (2017)

Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis
por: Weber, Daniel G., et al.
Publicado: (2014)

Re-evaluation of potential predictors of calretinin and mesothelin in a population-based cohort study using assays for the routine application in clinical medicine
por: Casjens, Swaantje, et al.
Publicado: (2021)

Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma
por: Kresoja-Rakic, Jelena, et al.
Publicado: (2017)

Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population
por: Aguilar-Madrid, Guadalupe, et al.
Publicado: (2018)

Serum Calretinin as a Biomarker in Malignant Mesothelioma
por: Zupanc, Cita, et al.
Publicado: (2021)

A molecular phenotypic map of malignant pleural mesothelioma
por: Di Genova, Alex, et al.
Publicado: (2023)

Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study
por: Xanthopoulos, Athanasios, et al.
Publicado: (2008)

Exploring solid-phase proximity ligation assay for survivin detection in urine
por: Gleichenhagen, Jan, et al.
Publicado: (2022)

Diagnostic Accuracy of Calretinin for Malignant Mesothelioma in Serous Effusions: a Meta-analysis
por: Li, Diandian, et al.
Publicado: (2015)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Identification of miRNA-103 in the Cellular Fraction of Human Peripheral Blood as a Potential Biomarker for Malignant Mesothelioma – A Pilot Study
por: Weber, Daniel G., et al.
Publicado: (2012)

Regulation of calretinin in malignant mesothelioma is mediated by septin 7 binding to the CALB2 promoter
por: Blum, Walter, et al.
Publicado: (2018)

Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study
por: Ac\ˇkar, Lucija, et al.
Publicado: (2021)

Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway
por: Wörthmüller, Janine, et al.
Publicado: (2018)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Intraoperative argon-plasma coagulation treatment for patients with malignant pleural mesothelioma
por: Iyoda, Akira, et al.
Publicado: (2021)

Thoracoscopy in Pleural Malignant Mesothelioma Diagnosis
por: Tassi, G. F., et al.
Publicado: (1997)

Imaging in staging of malignant pleural mesothelioma
por: Truong, Mylene T, et al.
Publicado: (2004)

Hedgehog Signaling in Malignant Pleural Mesothelioma
por: Felley-Bosco, Emanuela, et al.
Publicado: (2015)

Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017)

Multimodality treatment of malignant pleural mesothelioma
por: Berzenji, Lawek, et al.
Publicado: (2018)

Modern management of malignant pleural mesothelioma
por: Patel, Shivani C, et al.
Publicado: (2016)

Pleural tuberculosis mimicking malignant mesothelioma
por: Dawood, Wajahat, et al.
Publicado: (2019)

Cytomegalovirus infection in malignant pleural mesothelioma
por: Hunter-Schlichting, DeVon, et al.
Publicado: (2021)

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
por: Terenziani, Rita, et al.
Publicado: (2021)

Advances in Immunotherapy of Malignant Pleural Mesothelioma
por: Liao, Dongying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tgehi9r7oeqa0b7s6cjcvc907d